Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Decoding the contribution of TDP-43 for synaptic failure in Alzheimer's Disease

Project description

Molecular insight into Alzheimer’s synaptic dysfunction

TDP-43 is an RNA-binding protein that regulates RNA processing, transport, stability and translation of genes involved in synaptic function. TDP-43 is lost from the nucleus and forms abnormal inclusions in the brain in about half of patients with Alzheimer’s disease (AD). Although such TDP-43 dysfunction is linked to faster brain degeneration and greater cognitive decline, the underlying mechanism remains poorly understood. With the support of the Marie Skłodowska-Curie Actions programme, the SynTDP project will investigate how TDP-43 loss contributes to synaptic dysfunction in AD. Researchers will utilise post-mortem brain tissue and mouse models to reveal synaptic RNA and protein changes caused by TDP-43 loss. Findings could reveal new therapeutic targets for slowing AD progression.

Objective

Alzheimer’s Disease (AD) is an adult-onset disorder characterized by progressive neuronal loss and synaptic dysfunction, leading to severe cognitive decline. Nuclear loss and pathological inclusions of TDP-43 protein have been identified in 20-50% of AD patients, which associate with higher odds of cognitive decline, and faster brain atrophy rates. TDP-43 regulates RNA metabolism, and many of its RNA targets converge at synaptic function. Studies from me and others identified TDP-43 dependent mis-splicing in AD patients with TDP-43 pathology, strongly suggesting that TDP-43 loss-of-function is an important, yet understudied, pathway in AD. Here, I hypothesize that TDP-43 loss-of-function in AD leads to defects in its synaptic RNA targets, which in turn contribute to synaptic dysfunction and thus cognitive defects. I will use post-mortem tissue, induced pluripotent stem cells (iPSCs) and mouse models to characterize the impact of TDP-43 loss in synaptic function and composition, and matched these with RNA alterations resulting from TDP-43 loss-of-function. This will uncover novel synaptic signatures of TDP-43 dysfunction in AD, and offer new insights into neurodegeneration in AD.

I will leverage my PhD training in synapse physiology and postdoctoral expertise in TDP-43 proteinopathy while working under the guidance of Dr. Ana Luísa Carvalho, a leading expert in synapse biology of disease. Dr. Carvalho is a dedicated mentor, and her lab at the Center for Neuroscience and Cell Biology (CNC) in Portugal is part of a top-tier research center with state-of-the-art facilities and a vibrant academic environment. This experience will be crucial for developing the scientific and transferable skills needed to achieve my goal of becoming an independent researcher within 2-3 years. I am enthusiastic about this opportunity and believe the MSCA postdoctoral fellowship would be transformative for my career and personal development.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

UNIVERSIDADE DE COIMBRA
Net EU contribution
€ 207 183,12
Address
PACO DAS ESCOLAS
3004-531 Coimbra
Portugal
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data